Asenar
.
///
Borsa
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
⌂
☀️
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
Sabitler
Temettüler
Blog
Ekip
Giriş
Çıkış
BIST Hub
›
Health Care Equipment & Supplies
› MEDTR
Research
BIST: MEDTR
MEDİTERA TIBBİ MALZEME SANAYİ VE TİCARET A.Ş.
BIST Main
Halal
İzmir
🔔
Set Alert
⚖
Compare
Share
29.86 TRY
Source:
KAP
Market Cap
TRY
3,553,340,000 TRY
USD
$78,671,154
EUR
—
1 USD = 45.17 TRY
Current Snapshot
- 2025 Q4
P/E Ratio
37.56x
↓ vs prior period
P/B Ratio
1.22x
↓ vs prior period
Gross Margin
30.48%
Op. Margin
3.29%
↑ vs prior period
Net Margin
3.29%
↓ vs prior period
ROE
3.26%
↑ vs prior period
ROA
2.63%
Source:
KAP
Debt / Equity
0.23x
↓ vs prior period
Current Ratio
3.36x
Liquidity check
Equity Ratio
80.93%
Asset coverage
EV / EBIT
37.56x
↓ vs prior period
Op. profit proxy
EV / Sales
1.24x
↓ vs prior period
Enterprise value
Piotroski F
4/9
Neutral (4/9)
Altman Z-Score
5.67
↑ vs prior period
Safe Zone ✓
Sector Benchmarks
KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE
22.0%
Net Margin
10.0%
Current Ratio
1.17x
Debt/Equity
0.73x
Earnings
— Q4 2025
Net Income YoY
(vs Q4 2024)
▼ -58.7%
95M TRY vs 229M TRY
Revenue YoY
(vs Q4 2024)
▲ +37.2%
2.9B TRY vs 2.1B TRY
Net Income QoQ
(vs Q3 2025)
▲ +10.8%
95M TRY vs 85M TRY
Revenue QoQ
(vs Q3 2025)
▲ +43.8%
2.9B TRY vs 2.0B TRY
Latest KAP Filings
Loading filings...
Sector Peers
View all in sector →
MPARK
MLP SAĞLIK HİZMETLERİ A.Ş.
P/E 8.0
ROE 30.5%
85.0B
ONCSM
ONCOSEM ONKOLOJİK SİSTEMLER SA
P/E 42.4
ROE 37.9%
6.5B
LKMNH
LOKMAN HEKİM ENGÜRÜSAĞ SAĞLIK
P/E 6.2
ROE 22.2%
3.3B
SEYKM
SEYİTLER KİMYA SANAYİ A.Ş.
P/E —
ROE -4.6%
1.1B
🔒
Unlock Full Analysis
AI-powered analysis, historical charts and full financial data for all 729 BIST companies.
AI Analysis — strengths, risks & outlook
Financial Charts — revenue, margins, returns, valuation
Historical Comparison — full quarterly data table
Get Premium Access
Sign in to your account →
Have a legacy key?
Activate
AI Analysis
Financial Charts
Revenue vs Net Income (1M TRY)
Equity vs Liabilities (1M TRY)
Profit Margins (%)
Returns — ROE vs ROA (%)
Valuation — P/E vs P/B
Advanced Analytics
Profit Cascade (1M TRY)
Revenue & Net Income Growth % (vs prior period)
3-Layer Margin Analysis — Gross, Operating, Net (%)
DuPont ROE Decomposition
Debt Structure — Current Liabilities + Long-term Debt (1M TRY)
Get DCF Valuation
PREMIUM
Historical Comparison
Period
Revenue (1M TRY)
Net Income
Net Margin
ROE
ROA
D/E
P/E
P/B
2022 Q4
806,039,290
226,441,594
28.09%
25.57%
20.60%
0.24x
15.69x
4.01x
2023 Q4
1,452,267,569
271,479,386
18.69%
18.42%
14.34%
0.28x
13.09x
2.41x
2024 Q3
737,182,543
24,511,415
3.33%
1.18%
0.93%
0.26x
108.73x
1.71x
2024 Q4
2,094,352,590
228,995,739
10.93%
10.27%
8.15%
0.26x
15.52x
1.59x
2025 Q1
600,349,960
-69,994,604
-11.66%
-2.91%
-2.33%
0.25x
N/A
1.48x
2025 Q2
619,428,134
-19,558,473
-11.66%
-2.91%
-2.33%
0.25x
N/A
1.48x
2025 Q3
1,998,326,546
85,412,412
-7.47%
-3.70%
-2.93%
0.26x
N/A
1.40x
2025 Q4
2,873,632,332
94,603,987
-3.16%
-0.77%
-0.61%
0.27x
N/A
1.40x